Edwards Lifesciences Corporation (EW)
- Previous Close
87.75 - Open
87.88 - Bid 88.05 x 1100
- Ask 89.00 x 800
- Day's Range
87.70 - 89.17 - 52 Week Range
60.57 - 96.12 - Volume
2,550,478 - Avg. Volume
4,005,437 - Market Cap (intraday)
53.337B - Beta (5Y Monthly) 1.07
- PE Ratio (TTM)
38.53 - EPS (TTM)
2.30 - Earnings Date Apr 25, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
94.52
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
www.edwards.comRecent News: EW
Performance Overview: EW
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EW
Valuation Measures
Market Cap
52.82B
Enterprise Value
51.87B
Trailing P/E
38.15
Forward P/E
32.05
PEG Ratio (5yr expected)
5.04
Price/Sales (ttm)
8.91
Price/Book (mrq)
7.94
Enterprise Value/Revenue
8.64
Enterprise Value/EBITDA
29.46
Financial Highlights
Profitability and Income Statement
Profit Margin
23.35%
Return on Assets (ttm)
12.25%
Return on Equity (ttm)
22.34%
Revenue (ttm)
6B
Net Income Avi to Common (ttm)
1.4B
Diluted EPS (ttm)
2.30
Balance Sheet and Cash Flow
Total Cash (mrq)
1.64B
Total Debt/Equity (mrq)
10.34%
Levered Free Cash Flow (ttm)
751.03M
Research Analysis: EW
Company Insights: EW
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: EW
EW: Lowering target price to $92.00
EDWARDS LIFESCIENCES CORP has an Investment Rating of HOLD; a target price of $92.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetEW: Lowering target price to $95.00
EDWARDS LIFESCIENCES CORP has an Investment Rating of HOLD; a target price of $95.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetEW: Lowering target price to $98.00
EDWARDS LIFESCIENCES CORP has an Investment Rating of HOLD; a target price of $98.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetEW: Raising target price to $99.00
EDWARDS LIFESCIENCES CORP has an Investment Rating of HOLD; a target price of $99.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target